Association of the Apolipoprotein A-I gene polymorphisms with cardiovascular disease risk factors and atherogenic indices in patients from assam, Northeast India
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics – 2015 update: A report from the American Heart Association. Circulation. 2015; 131(4): e29-e322. 10.1161/CIR.0000000000000152.MozaffarianDBenjaminEJGoASArnettDKBlahaMJCushmanMHeart disease and stroke statistics – 2015 update: A report from the American Heart AssociationCirculation.20151314e29e32210.1161/CIR.0000000000000152Open DOISearch in Google Scholar
Remaley AT, Rifai N, Warnick GR. Lipids, lipoproteins, apolipoproteins and cardiovascular risk factors. In: Burtis CA, Ashwood ER, Bruns DE, Eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 5th ed., 1st Indian reprint. New Delhi, India: Elsevier (Reed Elsevier India Pvt. Ltd.). 2012: 731-805.RemaleyATRifaiNWarnickGR.Lipids, lipoproteins, apolipoproteins and cardiovascular risk factorsBurtisCAAshwoodERBrunsDETietz Textbook of Clinical Chemistry and Molecular Diagnostics5th1st Indian reprintNew Delhi IndiaElsevier (Reed Elsevier India Pvt. Ltd.)2012731805Search in Google Scholar
Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97(18): 1837-1847.WilsonPWD’AgostinoRBLevyDBelangerAMSilbershatzHKannelWB.Prediction of coronary heart disease using risk factor categoriesCirculation.1998971818371847Search in Google Scholar
Dallinga-Thie GM, Bu XD, Trip MLS, Rotter JI, Lusis AJ, de Bruin TWA. Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: Effects on LDL-cholesterol and apolipoproteins B and C-III. J Lipid Res. 1996; 37(1): 136-147.Dallinga-ThieGMBuXDTripMLSRotterJILusisAJde BruinTWA.Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: Effects on LDL-cholesterol and apolipoproteins B and C-IIIJ Lipid Res.1996371136147Search in Google Scholar
Wojciechowski AP, Farrall M, Cullen P, Wilson TME, Bayliss JD, Farren B, et al. Familial combined hyperlipidaemia linked to the apolipoprotein AI-CIII-AIV gene cluster on chromosome 11q23q-q24. Nature. 1991; 349(6305): 161-164.WojciechowskiAPFarrallMCullenPWilsonTMEBaylissJDFarrenBFamilial combined hyperlipidaemia linked to the apolipoprotein AI-CIII-AIV gene cluster on chromosome 11q23q-q24Nature.19913496305161164Search in Google Scholar
de Franca E, Alves JG, Hutz MH. APOA1/C3/A4 gene cluster variability and lipid levels in Brazilian children. Braz J Med Biol Res. 2005; 38(4): 535-541.de FrancaEAlvesJGHutzMH.APOA1/C3/A4 gene cluster variability and lipid levels in Brazilian childrenBraz J Med Biol Res.2005384535541Search in Google Scholar
Ding Y, Zhu MA, Wang ZX, Zhu J, Feng JB, Li DS. Associations of polymorphisms in the apolipoprotein APOA1-C3-A5 gene cluster with acute coronary syndrome. J Biomed Biotechnol. 2012; 2012: 509420. 10.1155/2012/509420.DingYZhuMAWangZXZhuJFengJBLiDS.Associations of polymorphisms in the apolipoprotein APOA1-C3-A5 gene cluster with acute coronary syndromeJ Biomed Biotechnol.2012201250942010.1155/2012/509420Open DOISearch in Google Scholar
Swanson CR, Li K, Unger TL, Gallagher MD, van Deerlin VM, Agarwal P, et al. Lower plasma apolipoprotein A1 levels are found in Parkinson’s disease and associate with apolipoprotein A1 genotype. Mov Disord. 2015; 30(6): 805-812.SwansonCRLiKUngerTLGallagherMDvan DeerlinVMAgarwalPLower plasma apolipoprotein A1 levels are found in Parkinson’s disease and associate with apolipoprotein A1 genotypeMov Disord.2015306805812Search in Google Scholar
Smach MA, Edziri H, Charfeddine B, Ben Othman L, Lammouchi T, Ltaief A, et al. Polymorphism in apoA1 influences high-density lipoprotein cholesterol levels but is not a major risk factor of Alzheimer’s disease. Dement Geriatr Cogn Disord Extra. 2011; 1(1): 249-257.SmachMAEdziriHCharfeddineBBen OthmanLLammouchiTLtaiefAPolymorphism in apoA1 influences high-density lipoprotein cholesterol levels but is not a major risk factor of Alzheimer’s diseaseDement Geriatr Cogn Disord Extra.201111249257Search in Google Scholar
Liu ZH, Xiao YM, Tang LY, Jiang L, Wang YJ, Zhang RC, et al. Apolipoprotein A1 -75 G/A and +83 C/T polymorphisms and renal cancer risk. Lipids Health Dis. 2015; 14: 143. 10.1186/s12944-015-0132-0.LiuZHXiaoYMTangLYJiangLWangYJZhangRCApolipoprotein A1 -75 G/A and +83 C/T polymorphisms and renal cancer riskLipids Health Dis.20151414310.1186/s12944-015-0132-0Open DOISearch in Google Scholar
Hsu MC, Lee KT, Hsiao WC, Wu CH, Sun HY, Lin IL, et al. The dyslipidemia-associated SNP on the APOA1/C3/A5 gene cluster predicts post-surgery poor outcome in Taiwanese breast cancer patients: A 10-year follow-up study. BMC Cancer. 2013; 13: 330. 10.1186/1471-2407-13-330.HsuMCLeeKTHsiaoWCWuCHSunHYLinILThe dyslipidemia-associated SNP on the APOA1/C3/A5 gene cluster predicts post-surgery poor outcome in Taiwanese breast cancer patients: A 10-year follow-up studyBMC Cancer.20131333010.1186/1471-2407-13-330Open DOISearch in Google Scholar
Miroshnikova VV, Rodygina TI, Demina EP, Kurjanov PS, Urazgildeeva SA, Gurevich VS, et al. Association of apoprotein A-1 genetic variants with development of atherosclerosis in the population of St. Petersburg. Russian J Genet Appl Res. 2011; 1: 411-415. 10.1134/S207905971105011X.MiroshnikovaVVRodyginaTIDeminaEPKurjanovPSUrazgildeevaSAGurevichVSAssociation of apoprotein A-1 genetic variants with development of atherosclerosis in the population of St. PetersburgRussian J Genet Appl Res.2011141141510.1134/S207905971105011XOpen DOISearch in Google Scholar
Coban N, Onat A, Guclu-Geyik F, Komurcu-Bayrak E, Can G, Erginel-Unaltuna N. Gender-specific associations of the APOA1 -75G>A polymorphism with several metabolic syndrome components in Turkish adults. Clin Chim Acta. 2014; 431: 244-249. 10.1016/j.cca.2014.01.017.CobanNOnatAGuclu-GeyikFKomurcu-BayrakECanGErginel-UnaltunaN.Gender-specific associations of the APOA1 -75G>A polymorphism with several metabolic syndrome components in Turkish adultsClin Chim Acta.201443124424910.1016/j.cca.2014.01.017Open DOISearch in Google Scholar
Souverein OW, Jukema JW, Boekholdt SM, Zwinderman AH, Tanck MWT. Polymorphisms in APOA1 and LPL genes are statistically independently associated with fasting TG in men with CAD. Eur J Hum Genet. 2005; 13(4): 445-451.SouvereinOWJukemaJWBoekholdtSMZwindermanAHTanckMWT.Polymorphisms in APOA1 and LPL genes are statistically independently associated with fasting TG in men with CADEur J Hum Genet.2005134445451Search in Google Scholar
Wang XL, Badenhop R, Humphrey K, Wilcken DE. New MspI polymorphism at +83 bp of the human apolipoprotein A1 gene: Association with increased circulating high density lipoprotein cholesterol levels. Genet Epidemiol. 1996; 13(1): 1-10.WangXLBadenhopRHumphreyKWilckenDE.New MspI polymorphism at +83 bp of the human apolipoprotein A1 gene: Association with increased circulating high density lipoprotein cholesterol levelsGenet Epidemiol.1996131110Search in Google Scholar
Dawar R, Gurtoo A, Singh R. Apolipoprotein A1 gene polymorphism (G-75A and C+83T) in patients with myocardial infarction: A pilot study in a North Indian population. Am J Clin Pathol. 2010; 134(2): 249-255.DawarRGurtooASinghR.Apolipoprotein A1 gene polymorphism (G-75A and C+83T) in patients with myocardial infarction: A pilot study in a North Indian populationAm J Clin Pathol.20101342249255Search in Google Scholar
Liao BH, Cheng KQ, Dong SH, Liu HD, Xu ZL. Effect of apolipoprotein A1 genetic polymorphisms on lipid profiles and the risk of coronary artery disease. Diagn Pathol. 2015; 10: 102. 10.1186/s13000-015-0328-7LiaoBHChengKQDongSHLiuHDXuZL.Effect of apolipoprotein A1 genetic polymorphisms on lipid profiles and the risk of coronary artery diseaseDiagn Pathol.20151010210.1186/s13000-015-0328-7Open DOISearch in Google Scholar
Kim YR, Hong SH. The apolipoprotein A1 polymorphisms were associated with decreased risk for metabolic syndrome in Koreans. Genes Genome. 2015; 37(10): 875-882. 10.1007/s13258-015-0318-x.KimYRHongSH.The apolipoprotein A1 polymorphisms were associated with decreased risk for metabolic syndrome in KoreansGenes Genome.2015371087588210.1007/s13258-015-0318-xOpen DOISearch in Google Scholar
Pagani F, Sidoli A, Giudichi GA, Barenghi L, Vergani C, Baralle FE. Human apolipoprotein A-I gene promoter polymorphism: Association with hyperalphalipoproteinemia. J Lipid Res. 1990; 31(8): 1371-1377.PaganiFSidoliAGiudichiGABarenghiLVerganiCBaralleFE.Human apolipoprotein A-I gene promoter polymorphism: Association with hyperalphalipoproteinemiaJ Lipid Res.199031813711377Search in Google Scholar
Wang XL, Badenhop R, Humphrey K, Wilcken DEL. C to T and G to A transitions are responsible for loss of a MspI restriction site in the 59-region of the human apolipoprotein AI gene. Hum Genet. 1995; 95(4): 473-475.WangXLBadenhopRHumphreyKWilckenDEL.C to T and G to A transitions are responsible for loss of a MspI restriction site in the 59-region of the human apolipoprotein AI geneHum Genet.1995954473475Search in Google Scholar
Bora K, Pathak MS, Borah P, Hussian MI, Das D. Single nucleotide polymorphisms of APOA1 gene and their relationship with serum apolipoprotein A-I concentrations in the native population of Assam. Meta Gene. 2016; 7: 20-27. 10.1016/j.mgene.2015.10.005.BoraKPathakMSBorahPHussianMIDasD.Single nucleotide polymorphisms of APOA1 gene and their relationship with serum apolipoprotein A-I concentrations in the native population of AssamMeta Gene.20167202710.1016/j.mgene.2015.10.005Open DOISearch in Google Scholar
Bora K, Pathak MS, Borah P, Das D. Variation in lipid profile across different patterns of obesity – Observations from Guwahati, Assam. J Clin Diagn Res. 2015; 9(11): OC17-OC21.BoraKPathakMSBorahPDasD.Variation in lipid profile across different patterns of obesity – Observations from Guwahati AssamJ Clin Diagn Res.2015911OC17OC21Search in Google Scholar
Kotokey R, Hazarika S, De A. Lipid abnormalities in hypertensive urban population of Dibrugarh district of upper Assam. Indian Heart J. 2006; 58(6): 405-408.KotokeyRHazarikaSDeA.Lipid abnormalities in hypertensive urban population of Dibrugarh district of upper AssamIndian Heart J.2006586405408Search in Google Scholar
Gururaj G, Girish N, Isaac MK. Mental, neurological and substance abuse disorders: Strategies towards a systems approach. In: National Commission on Macroeconomics and Health (NCMH) Background Papers – Burden of disease in India. New Delhi, India: NCMH, Ministry of Health & Family Welfare, Government of India. 2005: 226-250.GururajGGirishNIsaacMK.Mental, neurological and substance abuse disorders: Strategies towards a systems approachNational Commission on Macroeconomics and Health (NCMH) Background Papers – Burden of disease in IndiaNew Delhi IndiaNCMH, Ministry of Health & Family Welfare Government of India2005226250Search in Google Scholar
National Cardiovascular Disease Database. Ministry of Health & Family Welfare, Government of India and World Health Organisation. http://www.searo.who.int/india/topics/cardiovascular_diseases/NCD_Resources_National_CVD_database-Final_Report.pdf. (Last accessed on June 21 2016.)National Cardiovascular Disease DatabaseMinistry of Health & Family Welfare Government of India and World Health Organisationhttp://www.searo.who.int/india/topics/cardiovascular_diseases/NCD_Resources_National_CVD_database-Final_Report.pdf(Last accessed on June 21 2016.)Search in Google Scholar
Shah SK, Saikia M, Snehlata C, Ramachandran A. High prevalence of type 2 diabetes in urban population of north eastern India. Int J Diabetes Dev Countries. 1999; 19: 144-147.ShahSKSaikiaMSnehlataCRamachandranA.High prevalence of type 2 diabetes in urban population of north eastern IndiaInt J Diabetes Dev Countries.199919144147Search in Google Scholar
Ridkar PM, Rifai N, Cook NR, Bradwin G, Buring JE. Non-HDL cholesterol, apolipoproteins A-1 and B-100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA. 2005; 294(3): 326-333.RidkarPMRifaiNCookNRBradwinGBuringJE.Non-HDL cholesterol, apolipoproteins A-1 and B-100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in womenJAMA.20052943326333Search in Google Scholar
Pereira T. Dyslipidemia and cardiovascular risk: lipid ratios as risk factors for cardiovascular disease. In: Kelishandi R, Ed. Dyslipidemia – From Prevention to Treatment. Rijeka, Croatia: InTech Europe. 2012: 279-302.PereiraT.Dyslipidemia and cardiovascular risk: lipid ratios as risk factors for cardiovascular diseaseKelishandiRDyslipidemia – From Prevention to Treatment. RijekaCroatiaInTech Europe2012279302Search in Google Scholar
Kennel WB. Risk stratification of dyslipidemia: Insights from the Framingham Study. Curr Med Chem Cardiovasc Hematol Agents. 2005; 3(3): 187-193.KennelWB.Risk stratification of dyslipidemia: Insights from the Framingham StudyCurr Med Chem Cardiovasc Hematol Agents.200533187193Search in Google Scholar
National Cholesterol Education Program. Third and Final report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Circulation. 2002; 106(25): 3143-3421.National Cholesterol Education Program. Third and Final report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)Circulation20021062531433421Search in Google Scholar
World Health Organisation. Annex 2: Recom-mended measurement protocols and derivation of indices. In: World Health Organisation Technical Report Series 854, Physical Status: The Use and Interpretation of An-thropometry. Geneva, Switzerland: World Health Organisation, 1995: 424-438.World Health Organisation. Annex 2: Recom-mended measurement protocols and derivation of indicesWorld Health Organisation Technical Report Series 854, Physical Status: The Use and Interpretation of An-thropometryGeneva, SwitzerlandWorld Health Organisation1995424438Search in Google Scholar
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA. 2003; 289(19): 2560-2572.ChobanianAVBakrisGLBlackHRCushmanWCGreenLAIzzoJL JrSeventh report of the Joint National Committee on prevention detection, evaluation, and treatment of high blood pressureJAMA.20032891925602572Search in Google Scholar
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the low-density lipoprotein cholesterol concentration in plasma without the use of preparative centrifuge. Clin Chem. 1972; 18(6): 499-502.FriedewaldWTLevyRIFredricksonDS.Estimation of the low-density lipoprotein cholesterol concentration in plasma without the use of preparative centrifugeClin Chem.1972186499502Search in Google Scholar
Castelli WP, Abbott RD, McNamara PM. Summary estimates of cholesterol used to predict coronary heart disease. Circulation. 1983; 67(4): 730-734.CastelliWPAbbottRDMcNamaraPM.Summary estimates of cholesterol used to predict coronary heart diseaseCirculation.1983674730734Search in Google Scholar
Dobiasova M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: Correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted-plasma (FERHDL). Clin Biochem. 2001; 34(7): 583-588.DobiasovaMFrohlichJ.The plasma parameter log (TG/HDL-C) as an atherogenic index: Correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted-plasma (FERHDL)Clin Biochem.2001347583588Search in Google Scholar
Nunes SOV, de Melo LGP, de Castro MRP, Barbossa S, Vargas HO, Berk M, et al. Atherogenic index of plasma and atherogenic coefficient are increased in major depression and bipolar disorder, especially when comorbid with tobacco use disorder. J Affect Disord. 2015; 172: 55-62. 10.1016/j.jad.2014.09.038.NunesSOVde MeloLGPde CastroMRPBarbossaSVargasHOBerkMAtherogenic index of plasma and atherogenic coefficient are increased in major depression and bipolar disorder, especially when comorbid with tobacco use disorderJ Affect Disord.2015172556210.1016/j.jad.2014.09.038Open DOISearch in Google Scholar
Cohen J. Statistical Power Analysis for the Behavioral Sciences, 2nd ed. New York, NY, USA: Routledge Academic, 1969.CohenJ.Statistical Power Analysis for the Behavioral Sciences2ndNew York NY, USARoutledge Academic1969Search in Google Scholar
Al-Bustan SA, Al-Serri AE, Annice BG, Alnaqeeb MA, Ebrahim GA. Re-sequencing of the APOAI promoter region and the genetic association of the -75G>A polymorphism with increased cholesterol and low density lipoprotein levels among a sample of the Kuwaiti population. BMC Med Genet. 2013; 14: 90. 10.1186/1471-2350-14-90.Al-BustanSAAl-SerriAEAnniceBGAlnaqeebMAEbrahimGA.Re-sequencing of the APOAI promoter region and the genetic association of the -75G>A polymorphism with increased cholesterol and low density lipoprotein levels among a sample of the Kuwaiti populationBMC Med Genet.2013149010.1186/1471-2350-14-90Open DOISearch in Google Scholar
Saha N, Tay JS, Low PS, Humphries SE. Guanidine to adenine (G/A) substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI levels in Chinese non-smokers. Genet Epidemiol. 1994; 11(3): 255-264.SahaNTayJSLowPSHumphriesSE.Guanidine to adenine (G/A) substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI levels in Chinese non-smokersGenet Epidemiol1994113255264Search in Google Scholar
Qingwei Z, Mingpeng S, Ping S, Hua Z, Mengling Z. Interaction of alcohol and G to A substitution at the promoter region of apolipoprotein AI gene in determining plasma apolipoprotein AI levels in Yi and Han Chinese. Chinese Med J. 2000; 113(5): 471-474.QingweiZMingpengSPingSHuaZMenglingZ.Interaction of alcohol and G to A substitution at the promoter region of apolipoprotein AI gene in determining plasma apolipoprotein AI levels in Yi and Han ChineseChinese Med J.20001135471474Search in Google Scholar
Li Y, Yin R, Zhou Y, Deng Y, Yang D, Pan S, et al. Associations of the apolipoprotein A-I gene polymorphism and serum lipid levels in the Guangxi Hei Yi Zhuang and Han populations. Int J Mol Med. 2008; 21(6): 753-764.LiYYinRZhouYDengYYangDPanSAssociations of the apolipoprotein A-I gene polymorphism and serum lipid levels in the Guangxi Hei Yi Zhuang and Han populationsInt J Mol Med.2008216753764Search in Google Scholar
Kessling AM, Horsthempke B, Humphries SE. A study of DNA polymorphism around the human apolipoprotein AI gene in hyperlipidaemic and normal individuals. Clin Genet. 1985; 28(4): 296-306.KesslingAMHorsthempkeBHumphriesSE.A study of DNA polymorphism around the human apolipoprotein AI gene in hyperlipidaemic and normal individualsClin Genet.1985284296306Search in Google Scholar
Ma YQ, Thomas GN, Tomlinson B. Association of two apolipoprotein A-I gene MspI polymorphisms with lipid and blood pressure levels. Int J Cardiol. 2005; 102(2): 309-314.MaYQThomasGNTomlinsonB.Association of two apolipoprotein A-I gene MspI polymorphisms with lipid and blood pressure levelsInt J Cardiol.20051022309314Search in Google Scholar